ArticleOncoTargets and therapy2018

Biosimilar filgrastim vs filgrastim: a multicenter nationwide observational bioequivalence study in patients with chemotherapy-induced neutropenia.

Alper Sevinç et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.